Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Møller, J. Gjedsted, L. Gormsen, J. Fuglsang, C. Djurhuus (2003)
Effects of growth hormone on lipid metabolism in humans.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 13 Suppl A
T. Williams, M. Berelowitz, S. Joffe, M. Thorner, J. Rivier, W. Vale, L. Frohman (1984)
Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction.The New England journal of medicine, 311 22
T. Pratipanawatr, Wilailak Pratipanawatr, C. Rosen, R. Berria, M. Bajaj, K. Cusi, L. Mandarino, S. Kashyap, R. Belfort, R. DeFronzo (2002)
Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.American journal of physiology. Endocrinology and metabolism, 282 6
D. Freeman, J. Norrie, M. Caslake, A. Gaw, I. Ford, G. Lowe, D. O’Reilly, C. Packard, N. Sattar (2002)
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.Diabetes, 51 5
Michael Rasmussen, J. Frystyk, Teis Andersen, Leif Breum, J. Christiansen, Jannik Hilsted (1994)
The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone.Metabolism: clinical and experimental, 43 3
Alice Luna, Darrell Wilson, C. Wibbelsman, R. Brown, R. Nagashima, R. Hintz, R. Rosenfeld (1983)
Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels.The Journal of clinical endocrinology and metabolism, 57 2
L. Murphy, C. Seneviratne, P. Moreira, R. Reid (1991)
Enhanced expression of insulin-like growth factor-binding protein-I in the fasted rat: the effects of insulin and growth hormone administration.Endocrinology, 128 2
Jiang Hong, George Zhang, F. Dong, M. Rechler (2002)
Insulin-like Growth Factor (IGF)-binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells*The Journal of Biological Chemistry, 277
Kuk-Wha Lee, Liqun Ma, Xinmin Yan, Bingrong Liu, Xiao-kun Zhang, P. Cohen (2005)
Rapid Apoptosis Induction by IGFBP-3 Involves an Insulin-like Growth Factor-independent Nucleomitochondrial Translocation of RXRα/Nur77*Journal of Biological Chemistry, 280
E. Froesch, C. Schmid, J. Schwander, J. Zapf (1985)
Actions of insulin-like growth factors.Annual review of physiology, 47
L. Underwood, J. Thissen, Sylvie Lemozy, J. Ketelslegers, David Clemmons (1994)
Hormonal and nutritional regulation of IGF-I and its binding proteins.Hormone research, 42 4-5
C. Lang, T. Vary, R. Frost (2003)
Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis.Endocrinology, 144 9
A. Heald, K. Siddals, W. Fraser, W. Taylor, K. Kaushal, J. Morris, R. Young, Anne White, J. Gibson (2002)
Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.Diabetes, 51 8
N. Pørksen, M. Hussain, T. Bianda, B. Nyholm, J. Christiansen, P. Butler, J. Veldhuis, E. Froesch, O. Schmitz (1997)
IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion rates.The American journal of physiology, 272 3 Pt 1
S. Xuan, T. Kitamura, J. Nakae, K. Politi, Y. Kido, P. Fisher, M. Morroni, S. Cinti, M. White, P. Herrera, D. Accili, A. Efstratiadis (2002)
Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor.The Journal of clinical investigation, 110 7
A. Burger, B. Leyland-Jones, K. Banerjee, D. Spyropoulos, A. Seth (2005)
Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer.European journal of cancer, 41 11
D. Leroith, H. Werner, D. Beitner‐Johnson, Andcharles Roberts (1995)
Molecular and cellular aspects of the insulin-like growth factor I receptor.Endocrine reviews, 16 2
S. Wheatcroft, M. Kearney, A. Shah, V. Ezzat, J. Miell, M. Modo, S. Williams, W. Cawthorn, G. Medina-Gómez, A. Vidal-Puig, Jaswinder Sethi, P. Crossey (2007)
IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin ResistanceDiabetes, 56
Yarong Lu, P. Herrera, Yubin Guo, David Sun, Zheng-yi Tang, D. Leroith, Jun-li Liu (2004)
Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes.Diabetes, 53 12
P. Zenobi, S. Jaeggi-Groisman, W. Riesen, E. Michael, Roder, E. Froesch (1992)
Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.The Journal of clinical investigation, 90 6
J. Zapf, C. Schmid, E. Froesch (1984)
Biological and immunological properties of insulin-like growth factors (IGF) I and II.Clinics in endocrinology and metabolism, 13 1
P. Clauson, Kerstin Brismar, K. Hall, R. Linnarsson, Valdemar Grill (1998)
Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden.Scandinavian journal of clinical and laboratory investigation, 58 4
P. Carroll, M. Umpleby, E. Alexander, Virginia Egel, K. Callison, P. Sönksen, D. Russell-Jones (1998)
Recombinant human insulin‐like growth factor‐I (rhIGF‐I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF‐binding proteins, glucose levels and insulin treatmentClinical Endocrinology, 49
J. Frystyk, E. Vestbo, C. Skjærbæk, C. Mogensen, H. Ørskov (1995)
Free insulin-like growth factors in human obesity.Metabolism: clinical and experimental, 44 10 Suppl 4
I. Turkalj, U. Keller, R. Ninnis, S. Vosmeer, W. Stauffacher (1992)
Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man.The Journal of clinical endocrinology and metabolism, 75 5
T. Alexandrides, A. Moses, R. Smith (1989)
Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle.Endocrinology, 124 2
K. Tan, R. Baxter (1986)
Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age.The Journal of clinical endocrinology and metabolism, 63 3
M. Jenab, E. Riboli, R. Cleveland, T. Norat, S. Rinaldi, A. Nieters, C. Biessy, A. Tjønneland, A. Olsen, K. Overvad, H. Grønbæk, F. Clavel-Chapelon, M. Boutron‐Ruault, J. Linseisen, H. Boeing, T. Pischon, D. Trichopoulos, E. Oikonomou, A. Trichopoulou, S. Panico, P. Vineis, F. Berrino, R. Tumino, G. Masala, Petra Peters, C. Gils, H. Bueno-de-Mesquita, M. Ocké, E. Lund, M. Mendez, M. Tormo, A. Barricarte, C. Martínez-García, M. Dorronsoro, J. Quirós, G. Hallmans, R. Palmqvist, G. Berglund, J. Manjer, T. Key, N. Allen, S. Bingham, K. Khaw, A. Cust, R. Kaaks (2007)
Serum C‐peptide, IGFBP‐1 and IGFBP‐2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and NutritionInternational Journal of Cancer, 121
M. Wallander, K. Brismar, J. Öhrvik, L. Rydén, A. Norhammar (2006)
Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarctionDiabetologia, 49
Jane Kim, D. Accili (2002)
Signalling through IGF-I and insulin receptors: where is the specificity?Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 12 2
Vincent Poitout, R. Robertson (2002)
Minireview: Secondary β-Cell Failure in Type 2 Diabetes-A Convergence of Glucotoxicity and Lipotoxicity.Endocrinology, 143 2
R. Kaplan, H. Strickler, T. Rohan, R. Muzumdar, David Brown (2005)
Insulin-Like Growth Factors and Coronary Heart DiseaseCardiology in Review, 13
R. Jacob, E. Barrett, G. Plewe, K. Fagin, R. Sherwin (1989)
Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.The Journal of clinical investigation, 83 5
J. Silha, Y. Gui, L. Murphy (2002)
Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice.American journal of physiology. Endocrinology and metabolism, 283 5
Froesch Er, H. Bürgi, E. Ramseier, P. Bally, A. Labhart (1963)
ANTIBODY-SUPPRESSIBLE AND NONSUPPRESSIBLE INSULIN-LIKE ACTIVITIES IN HUMAN SERUM AND THEIR PHYSIOLOGIC SIGNIFICANCE. AN INSULIN ASSAY WITH ADIPOSE TISSUE OF INCREASED PRECISION AND SPECIFICITY.The Journal of clinical investigation, 42
D. Clemmons, D. Snyder, D. Snyder, W. Busby, W. Busby (1991)
Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects.The Journal of clinical endocrinology and metabolism, 73 4
D. Moller, A. Yokota, J. Caro, J. Flier (1989)
Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man.Molecular endocrinology, 3 8
F. Hu, J. Meigs, Tricia Li, N. Rifai, J. Manson (2004)
Inflammatory markers and risk of developing type 2 diabetes in women.Diabetes, 53 3
D. Voskuil, H. Mesquita, R. Kaaks, P. Noord, S. Rinaldi, E. Riboli, D. Grobbee, P. Peeters (2001)
Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1–3 in premenopausal women: physical activity and anthropometry (Netherlands)Cancer Causes & Control, 12
N. Rennert, S. Caprio, R. Sherwin (1993)
Insulin-like growth factor I inhibits glucose-stimulated insulin secretion but does not impair glucose metabolism in normal humans.The Journal of clinical endocrinology and metabolism, 76 3
S. Cousin, S. Hügl, C. Wrede, H. Kajio, M. Myers, C. Rhodes (2001)
Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1.Endocrinology, 142 1
Ping Wang, Ning Li, Jie‐shou Li, Wei-qin Li (2002)
The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity.World journal of gastroenterology, 8 3
J. Jørgensen, L. Møller, Morten Krag, N. Billestrup, J. Christiansen (2007)
Effects of growth hormone on glucose and fat metabolism in human subjects.Endocrinology and metabolism clinics of North America, 36 1
J. Frystyk, C. Skjærbæk, E. Vestbo, S. Fisker, H. Ørskov (1999)
Circulating levels of free insulin‐like growth factors in obese subjects: the impact of Type 2 diabetesDiabetes/Metabolism Research and Reviews, 15
R. Rajah, B. Valentinis, P. Cohen (1997)
Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism*The Journal of Biological Chemistry, 272
L. Mosthaf, K. Grako, T. Dull, Lisa Coussens, A. Ullrich, D. McClain (1990)
Functionally distinct insulin receptors generated by tissue‐specific alternative splicing.The EMBO Journal, 9
The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Elevated Serum Levels of Free Insulin-Like Growth Factor I in Polycystic Ovary Syndrome*
D. Roith (2002)
Insulin-like Growth Factors
John Wilding (2007)
The importance of free fatty acids in the development of Type 2 diabetesDiabetic Medicine, 24
L. Morrow, M. O'Brien, D. Moller, J. Flier, A. Moses (1994)
Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance.The Journal of clinical endocrinology and metabolism, 79 1
I. Bezemer, I. Bezemer, S. Rinaldi, L. Dossus, C. Gils, P. Peeters, P. Noord, H. Bueno-de-Mesquita, S. Johnsen, K. Overvad, A. Olsen, A. Tjønneland, H. Boeing, P. Lahmann, J. Linseisen, G. Nagel, N. Allen, A. Roddam, S. Bingham, K. Khaw, E. Kesse, B. Téhard, F. Clavel-Chapelon, A. Agudo, E. Ardanaz, J. Quirós, P. Amiano, C. Martínez-García, M. Tormo, V. Pala, S. Panico, P. Vineis, D. Palli, R. Tumino, A. Trichopoulou, N. Baibas, D. Zilis, Bertrand Hémon, T. Norat, E. Riboli, R. Kaaks (2005)
C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC)Cancer Causes & Control, 16
A. Butt, K. Fraley, S. Firth, R. Baxter (2002)
IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells.Endocrinology, 143 7
N. Bhattacharyya, K. Pechhold, H. Shahjee, G. Zappalá, C. Elbi, B. Raaka, M. Wiench, Jiang Hong, M. Rechler (2006)
Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus*Journal of Biological Chemistry, 281
Herbert Yu, J. Mistry, M. Nicar, M. Khosravi, A. Diamandis, J. Doorn, A. Juul (1999)
Insulin‐like growth factors (IGF‐I, free IGF‐I, and IGF‐II) and insulin‐like growth factor binding proteins (IGFBP‐2, IGFBP‐3, IGFBP‐6, and ALS) in blood circulationJournal of Clinical Laboratory Analysis, 13
K-W Lee, P. Cohen (2002)
Nuclear effects: unexpected intracellular actions of insulin-like growth factor binding protein-3.The Journal of endocrinology, 175 1
Roopa Rajah, L. Katz, S. Nunn, Paulo Solberg, Tara Beers, Pinchas Cohen (1995)
Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth.Progress in growth factor research, 6 2-4
V. Hwa, Y. Oh, Ron Rosenfeld (1999)
The insulin-like growth factor-binding protein (IGFBP) superfamily.Endocrine reviews, 20 6
T. O'Connell, D. Clemmons (2002)
IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms.The Journal of clinical endocrinology and metabolism, 87 9
J. Thissen, J. Ketelslegers, L. Underwood (1994)
Nutritional regulation of the insulin-like growth factors.Endocrine reviews, 15 1
R. Rajah, A. Khare, P. Lee, Pinchas Cohen (1999)
Insulin-like growth factor-binding protein-3 is partially responsible for high-serum-induced apoptosis in PC-3 prostate cancer cells.The Journal of endocrinology, 163 3
R. Muzumdar, Xiaohui Ma, S. Fishman, Xiaoman Yang, G. Atzmon, P. Vuguin, F. Einstein, David Hwang, P. Cohen, N. Barzilai (2006)
Central and Opposing Effects of IGF-I and IGF-Binding Protein-3 on Systemic Insulin ActionDiabetes, 55
E. Froesch, W. Müller, H. Bürgi, M. Waldvogel, A. Labhart (1966)
Non-suppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with non-suppressible insulin-like activity.Biochimica et biophysica acta, 121 2
J. Zapf, C. Hauri, M. Waldvogel, E. Froesch (1986)
Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.The Journal of clinical investigation, 77 6
I. Ofková (2003)
Pathophysiological and Clinical Importance of Insulin-Like Growth Factor-I with Respect to Bone Metabolism
R. Rajah, Kuk-Wha Lee, P. Cohen (2002)
Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation.Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 13 4
M. Wabitsch, Eberhard Heinze, K. Debatin, W. Blum (2000)
IGF-I- and IGFBP-3-expression in cultured human preadipocytes and adipocytes.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 32 11-12
Z. Laron,, D. Weinberger (2005)
Diabetic retinopathy, nephropathy and cardiovascular disease in a patient with GH gene deletionClinical Endocrinology, 63
M. Eivindson, J. Nielsen, H. Grønbæk, A. Flyvbjerg, H. Hey (2005)
The Insulin-Like Growth Factor System and Markers of Inflammation in Adult Patients with Inflammatory Bowel DiseaseHormone Research in Paediatrics, 64
J. Shepherd, A. Gaw (2002)
The Anatomy of a Clinical TrialMedical Principles and Practice, 11
S. Fanayan, S. Firth, A. Butt, R. Baxter (2000)
Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-β (TGF-β) and the Type II TGF-β Receptor*The Journal of Biological Chemistry, 275
S. Boulware, W. Tamborlane, J. N., Rennert, N. Gesundheit, R. Sherwin (1994)
Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.The Journal of clinical investigation, 93 3
K. Ueki, T. Okada, Jiang Hu, C. Liew, A. Assmann, Gabriella Dahlgren, J. Peters, J. Shackman, Min Zhang, I. Artner, L. Satin, R. Stein, M. Holzenberger, R. Kennedy, C. Kahn, R. Kulkarni (2006)
Total insulin and IGF-I resistance in pancreatic β cells causes overt diabetesNature Genetics, 38
Clifford Rosen (1999)
Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications.Clinical chemistry, 45 8 Pt 2
Steven Lieberman, J. Bukar, S. Chen, Abbie Celniker, P. Compton, J. Cook, Jeanine Albu, Andrew Perlman, Andrew Hoffman (1992)
Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.The Journal of clinical endocrinology and metabolism, 75 1
Guler Hp, J. Zapf, Froesch Er (1987)
Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults.The New England journal of medicine, 317 3
M. Federici, L. Zucaro, O. Porzio, R. Massoud, P. Borboni, D. Lauro, G. Sesti (1996)
Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects.The Journal of clinical investigation, 98 12
L. Cobb, Bingrong Liu, Kuk-Wha Lee, P. Cohen (2006)
Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3.Cancer research, 66 22
Adrian Heald, J. Cruickshank, Lisa Riste, Janet Cade, S. Anderson, A. Greenhalgh, J. Sampayo, W. Taylor, William Fraser, Anne White, J. Gibson (2001)
Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populationsDiabetologia, 44
P. Ripa, I. Robertson, D. Cowley, M. Harris, I. Masters, A. Cotterill (2002)
The relationship between insulin secretion, the insulin‐like growth factor axis and growth in children with cystic fibrosisClinical Endocrinology, 56
K. Woods, C. Camacho‐Hübner, D. Barter, Ajl Clark, M. Savage (1997)
Insulin‐like growth factor I gene deletion causing intrauterine growth retardation and severe short statureActa Paediatrica, 86
M. Federici, A. Giaccari, M. Hribal, B. Giovannone, D. Lauro, L. Morviducci, L. Pastore, G. Tamburrano, R. Lauro, G. Sesti (1999)
Evidence for glucose/hexosamine in vivo regulation of insulin/IGF-I hybrid receptor assembly.Diabetes, 48 12
C. Schmid, T. Bianda, C. Zwimpfer, J. Zapf, P. Wiesli (2005)
Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 15 4
K. Woods, C. Camacho‐Hübner, R. Bergman, D. Barter, A. Clark, M. Savage (2000)
Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion.The Journal of clinical endocrinology and metabolism, 85 4
R. Pratley, C. Weyer (2001)
The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitusDiabetologia, 44
S. Xuan, T. Kitamura, J. Nakae, K. Politi, Y. Kido, P. Fisher, M. Morroni, S. Cinti, M. White, P. Herrera, D. Accili, A. Efstratiadis (2002)
Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptorJournal of Clinical Investigation, 110
P. Zenobi, S. Graf, Heinz Ursprung, E. Froesch (1992)
Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.The Journal of clinical investigation, 89 6
M. Federici, O. Porzio, D. Lauro, P. Borboni, B. Giovannone, L. Zucaro, M. Hribal, G. Sesti (1998)
Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity.The Journal of clinical endocrinology and metabolism, 83 8
rd Moxley, P. Arner, A. Moss, A. Skottner, M. Fox, David James, James Livingston (1990)
Acute effects of insulin-like growth factor I and insulin on glucose metabolism in vivo.The American journal of physiology, 259 4 Pt 1
Guoliang Li, E. Barrett, Hong Wang, W. Chai, Zhenqi Liu (2005)
Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells.Endocrinology, 146 11
K. Kaushal, A. Heald, K. Siddals, M. Sandhu, D. Dunger, J. Gibson, N. Wareham (2004)
The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome.Diabetes care, 27 11
L. Katz, D. Deleon, Hui Zhao, A. Jawad (2002)
Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1.The Journal of clinical endocrinology and metabolism, 87 6
M. Sandhu, A. Heald, J. Gibson, J. Cruickshank, D. Dunger, N. Wareham (2002)
Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational studyThe Lancet, 359
D. Russell-Jones, A. Bates, A. Umpleby, T. Hennessy, S. Bowes, K. Hopkins, N. Jackson, J. Kelly, F. Shojaee-Moradie, Richard Jones, P. Sönksen (1995)
A comparison of the effects of IGF‐I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteersEuropean Journal of Clinical Investigation, 25
S. Firth, R. Baxter (2002)
Cellular actions of the insulin-like growth factor binding proteins.Endocrine reviews, 23 6
W. Daughaday, P. Rotwein (1989)
Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.Endocrine reviews, 10 1
Jie Fan, D. Char, G. Bagby, M. Gelato, C. Lang (1995)
Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor.The American journal of physiology, 269 5 Pt 2
R. Hochscheid, G. Jaques, B. Wegmann (2000)
Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer.The Journal of endocrinology, 166 3
A. Denley, J. Carroll, G. Brierley, L. Cosgrove, J. Wallace, B. Forbes, C. Roberts (2007)
Differential Activation of Insulin Receptor Substrates 1 and 2 by Insulin-Like Growth Factor-Activated Insulin ReceptorsMolecular and Cellular Biology, 27
L. Scavo, M. Karas, Malissa Murray, D. Leroith (2004)
Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes.The Journal of clinical endocrinology and metabolism, 89 7
G. Sesti, A. Sciacqua, M. Cardellini, M. Marini, R. Maio, M. Vatrano, E. Succurro, R. Lauro, M. Federici, F. Perticone (2005)
Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.Diabetes care, 28 1
S. Rajpathak, A. Mcginn, H. Strickler, T. Rohan, M. Pollak, A. Cappola, L. Kuller, X. Xue, A. Newman, E. Strotmeyer, B. Psaty, R. Kaplan (2008)
Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 18 2
A. Hennige, D. Burks, U. Ozcan, R. Kulkarni, Jing Ye, Sunmin Park, M. Schubert, T. Fisher, Matthew Dow, R. Leshan, M. Zakaria, M. Mossa-Basha, M. White (2003)
Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes.The Journal of clinical investigation, 112 10
J. Manetta, J. Brun, L. Maimoun, A. Callis, C. Prefaut, J. Mercier (2002)
Effect of training on the GH/IGF-I axis during exercise in middle-aged men: relationship to glucose homeostasis.American journal of physiology. Endocrinology and metabolism, 283 5
K. Robertson, Yarong Lu, Kristine Jesus, Bing Li, Qing Su, P. Lund, Jun-li Liu (2008)
A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.American journal of physiology. Endocrinology and metabolism, 294 5
M. Kelijman (1991)
Age‐Related Alterations of the Growth Hormone/Insulin‐Like‐Growth‐Factor I AxisJournal of the American Geriatrics Society, 39
D. Elahi, M. McAloon-Dyke, N. Fukagawa, A. Sclater, G. Wong, R. Shannon, K. Minaker, J. Miles, A. Rubenstein, C. Vandepol (1993)
Effects of recombinant human IGF-I on glucose and leucine kinetics in men.The American journal of physiology, 265 6 Pt 1
Y. Yamanaka, J. Fowlkes, E. Wilson, R. Rosenfeld, Y. Oh (1999)
Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule.Endocrinology, 140 3
K. Sakai, H. Lowman, D. Clemmons (2002)
Increases in Free, Unbound Insulin-like Growth Factor I Enhance Insulin Responsiveness in Human Hepatoma G2 Cells in Culture*The Journal of Biological Chemistry, 277
E. Rinderknecht, R. Humbel (1978)
The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.The Journal of biological chemistry, 253 8
P. Jenkins, S. Bustin (2004)
Evidence for a link between IGF-I and cancer.European journal of endocrinology, 151 Suppl 1
A. Barreca, P. Artini, A. Cesarone, M. Arvigo, G. D'ambrogio, A. Genazzani, G. Giordano, F. Minuto (1996)
Interrelationships between follicle stimulating hormone and the growth hormone - insulin-like growth factor - IGF-binding proteins axes in human granulosa cells in cultureJournal of Endocrinological Investigation, 19
A. Moses, Simon Young, L. Morrow, M. O'Brien, D. Clemmons (1996)
Recombinant Human Insulin-Like Growth Factor I Increases Insulin Sensitivity and Improves Glycemic Control in Type II DiabetesDiabetes, 45
SY Nam, E. Lee, KR Kim, B. Cha, Y. Song, SK Lim, H. Lee, K. Huh (1997)
Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormoneInternational Journal of Obesity, 21
M. Gunter, D. Hoover, Herbert Yu, S. Wassertheil-Smoller, T. Rohan, J. Manson, B. Howard, J. Wylie-Rosett, G. Anderson, G. Ho, R. Kaplan, Jixin Li, X. Xue, Tiffany Harris, R. Burk, H. Strickler (2007)
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.Cancer research, 68 1
A. Heald, S. Anderson, F. Ivison, I. Laing, J. Gibson, K. Cruickshank (2003)
C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.Atherosclerosis, 170 1
J. Janssen, S. Lamberts (1999)
Is the measurement of free IGF-I more indicative than that of total IGF-I in the evaluation of the biological activity of the GH/IGF-I axis?Journal of Endocrinological Investigation, 22
J. Gibson, M. Westwood, S. Crosby, C. Gordon, J. Holly, W. Fraser, C. Anderson, A. White, R. Young (1995)
Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.The Journal of clinical endocrinology and metabolism, 80 4
T. Saukkonen, R. Amin, Rachel Williams, C. Fox, K. Yuen, Martin White, A. Umpleby, C. Acerini, D. Dunger (2004)
Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.The Journal of clinical endocrinology and metabolism, 89 9
P. Zenobi, H. Guler, J. Zapf, E. Froesch (1988)
Insulin-like growth factors in the Göttinger miniature-pig.Acta endocrinologica, 117 3
Tim Cheetham, D. Dunger, K. Clayton, J. Holly, S. Cwyfan-Hughes (1995)
The Effects of Repeated Daily Recombinant Human Insulin‐like Growth Factor I Administration in Adolescents with Type 1 DiabetesDiabetic Medicine, 12
A. Juul, P. Bang, N. Hertel, K. Main, P. Dalgaard, K. Jørgensen, Jørn Müller, K. Hall, N. Skakkebæk (1994)
Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index.The Journal of clinical endocrinology and metabolism, 78 3
J. Bak, N. Møller, O. Schmitz (1991)
Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans.The American journal of physiology, 260 5 Pt 1
N. Golden, G. Pepper, T. Avruskin (1992)
in Women with
B. Samstein, M. Hoimes, J. Fan, R. Frost, M. Gelato, C. Lang (1996)
IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)-1 production.Biochemical and biophysical research communications, 228 2
Matthew Ellis, Brett Leav, Zejia Yang, A. Rasmussen, Amelia Pearce, James Zweibel, Marc Lippman, Kevin Cullen (1996)
Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.Molecular endocrinology, 10 3
K. Brismar, E. Fernqvist-Forbes, J. Wahren, K. Hall (1994)
Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes.The Journal of clinical endocrinology and metabolism, 79 3
A. Juul (2003)
Serum levels of insulin-like growth factor I and its binding proteins in health and disease.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 13 4
Ron Rosenfeld, V. Hwa, Elizabeth Wilson, S. Plymate, Y. Oh (2000)
The insulin-like growth factor-binding protein superfamily.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 10 Suppl A
T. Haeften, T. Twickler (2004)
Insulin‐like growth factors and pancreas beta cellsEuropean Journal of Clinical Investigation, 34
J. Frystyk (2004)
Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 14 5
L. Schedlich, Sophie Page, S. Firth, L. Briggs, D. Jans, R. Baxter (2000)
Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin β Subunit*The Journal of Biological Chemistry, 275
Zenobi Pd, Y. Glatz, A. Keller, S. Graf, Jaeggi-Groisman Se, Walter Riesen, Schoenle Ej, Froesch Er (1994)
Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A.European journal of endocrinology, 131 3
C. Liew, S. Wise, K. Yeo, K-O Lee (2005)
Insulin-like growth factor binding protein-1 is independently affected by ethnicity, insulin sensitivity, and leptin in healthy, glucose-tolerant young men.The Journal of clinical endocrinology and metabolism, 90 3
D. Modan-Moses, M. Janicot, J. Mclenithan, M. Lane, S. Casella (1998)
Expression and function of insulin/insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes.The Biochemical journal, 333 ( Pt 3)
G. Renier, I. Clément, A. Desfaits, A. Lambert (1996)
Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production.Endocrinology, 137 11
S. Nakanishi, K. Yamane, N. Kamei, M. Okubo, N. Kohno (2003)
Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans.Diabetes care, 26 10
G. Pandini, F. Frasca, R. Mineo, L. Sciacca, R. Vigneri, A. Belfiore (2002)
Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved*The Journal of Biological Chemistry, 277
C. Conover, Phillip Lee, J. Kanaley, J. Clarkson, M. Jensen (1992)
Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans.The Journal of clinical endocrinology and metabolism, 74 6
F. Nielsen, Enmei Wang, S. Gammeltoft (1991)
Receptor Binding, Endocytosis, and Mitogenesis of Insulin‐Like Growth Factors I and II in Fetal Rat Brain NeuronsJournal of Neurochemistry, 56
Jun-li Liu (2007)
Does IGF-I stimulate pancreatic islet cell growth?Cell Biochemistry and Biophysics, 48
S. Persaud, T. Harris, Christopher Burns, Peter Jones (1999)
Tyrosine kinases play a permissive role in glucose-induced insulin secretion from adult rat islets.Journal of molecular endocrinology, 22 1
J. Frystyk, T. Grøfte, C. Skjærbæk, Hans Ørskov (1997)
The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults.The Journal of clinical endocrinology and metabolism, 82 9
P. Jones, S. Persaud (1994)
Tyrosine kinase inhibitors inhibit glucose-stimulated insulin secretion.Biochemical Society transactions, 22 2
J. Luo, L. Murphy (1992)
Differential expression of the insulin-like growth factor binding proteins in spontaneously diabetic rats.Journal of molecular endocrinology, 8 2
Z. Laron,, D. Weinberger (2004)
Diabetic retinopathy in two patients with congenital IGF-I deficiency (Laron syndrome).European journal of endocrinology, 151 1
Mohamed-Ali, Pinkney, Panahloo, Cwyfan‐Hughes, Holly, Yudkin (1999)
Insulin‐like growth factor binding protein‐1 in NIDDM: relationship with the insulin resistance syndromeClinical Endocrinology, 50
S. Fanayan, S. Firth, A. Butt, R. Baxter (2000)
Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.The Journal of biological chemistry, 275 50
A. López‑Bermejo, J. Khosravi, J. Fernández-Real, V. Hwa, K. Pratt, R. Casamitjana, M. García-Gil, R. Rosenfeld, W. Ricart (2006)
Insulin Resistance Is Associated With Increased Serum Concentration of IGF-Binding Protein–Related Protein 1 (IGFBP-rP1/MAC25)Diabetes, 55
J. Gibson, M. Westwood, R. Young, A. White (1996)
Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM).The Journal of clinical endocrinology and metabolism, 81 2
B. Valentinis, A. Bhala, T. Deangelis, Renato Baserga, Pinchas Cohen (1995)
The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene.Molecular endocrinology, 9 3
R. Laager, U. Keller (1993)
Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and Type 2 (non-insulin-dependent) diabetic subjectsDiabetologia, 36
L. Shao, Q. Huang, M. Luo, M. Lai (2004)
Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients.Endocrine-related cancer, 11 1
M. Böni-Schnetzler, C. Schmid, P. Meier, E. Froesch (1991)
Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes.The American journal of physiology, 260 6 Pt 1
D. Roith (1997)
Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors.The New England journal of medicine, 336 9
M. Pollak (2000)
Insulin-like growth factor physiology and cancer risk.European journal of cancer, 36 10
(2002)
/dmrr apoptosis: role of Bcl-2 phosphorylation
(1994)
Characterization of a direct, non-extraction imunoradiometric assay for free IGF-I
(1991)
A 96-well microtiter plate assay for free IGF-I in plasma using immobilized IGFBP-3
J. Janssen, Ronald Stolk, H. Pols, D. Grobbee, D. Grobbee, F. Jong, S. Lamberts (1998)
Serum free IGF‐I, total IGF‐I, IGFBP‐1 and IGFBP‐3 levels in an elderly population: relation to age and sex steroid levelsClinical Endocrinology, 48
C. Lang, G. Nystrom, R. Frost (1999)
Regulation of IGF binding protein-1 in Hep G2 cells by cytokines and reactive oxygen species.American journal of physiology. Gastrointestinal and liver physiology, 276 3
B. Nyomba, L. Berard, L. Murphy (1997)
Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity.The Journal of clinical endocrinology and metabolism, 82 7
D. Clemmons (2006)
Involvement of insulin-like growth factor-I in the control of glucose homeostasis.Current opinion in pharmacology, 6 6
M. Oufattole, S. Lin, Bingrong Liu, D. Mascarenhas, P. Cohen, B. Rodgers (2006)
Ribonucleic acid polymerase II binding subunit 3 (Rpb3), a potential nuclear target of insulin-like growth factor binding protein-3.Endocrinology, 147 5
H. Nørrelund (2005)
The metabolic role of growth hormone in humans with particular reference to fasting.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 15 2
R. Kulkarni (2005)
New insights into the roles of insulin/IGF-I in the development and maintenance of beta-cell mass.Reviews in endocrine & metabolic disorders, 6 3
B. Rodgers, E. Roalson, C. Thompson (2008)
Phylogenetic analysis of the insulin-like growth factor binding protein (IGFBP) and IGFBP-related protein gene families.General and comparative endocrinology, 155 1
V. Poitout, R. Robertson (2002)
Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity.Endocrinology, 143 2
M. Holzenberger, L. Kappeler, C. Filho (2004)
IGF-1 signaling and agingExperimental Gerontology, 39
K. Ueki, T. Okada, Jiang Hu, C. Liew, A. Assmann, Gabriella Dahlgren, J. Peters, J. Shackman, Min Zhang, I. Artner, L. Satin, R. Stein, M. Holzenberger, R. Kennedy, C. Kahn, R. Kulkarni (2006)
Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes.Nature genetics, 38 5
D. Owens, L. Cozma, S. Luzio (2002)
Early-phase prandial insulin secretion: its role in the pathogenesis of type 2 diabetes mellitus and its modulation by repaglinide.Diabetes, nutrition & metabolism, 15 6 Suppl
E. Szoke, J. Gerich (2005)
Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitusComprehensive Therapy, 31
Ping Wang, Ning Li, Jie‐shou Li, Wei-qin Li (2002)
The role of endotoxin, TNF-α α α α α , and IL-6 in inducing the state of growth hormone insensitivity
M. Federici, O. Porzio, L. Zucaro, B. Giovannone, P. Borboni, M. Marini, D. Lauro, G. Sesti (1997)
Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patientsMolecular and Cellular Endocrinology, 135
T. Modric, J. Silha, Zengdun Shi, Y. Gui, A. Suwanichkul, S. Durham, D. Powell, L. Murphy (2001)
Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice.Endocrinology, 142 5
Jian-wen Chen, K. Højlund, H. Beck-Nielsen, J. Christiansen, H. Orskov, J. Frystyk (2005)
Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects.The Journal of clinical endocrinology and metabolism, 90 1
D. Goodman-gruen, E. Barrett-Connor (1997)
Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study.American journal of epidemiology, 145 11
M. Lewitt, G. Denyer, G. Cooney, R. Baxter (1991)
Insulin-like growth factor-binding protein-1 modulates blood glucose levels.Endocrinology, 129 4
M. Federici, D. Lauro, M. D’Adamo, B. Giovannone, O. Porzio, M. Mellozzi, G. Tamburrano, P. Sbraccia, G. Sesti (1998)
Expression of Insulin/IGF-I Hybrid Receptors Is Increased in Skeletal Muscle of Patients With Chronic Primary HyperinsulinemiaDiabetes, 47
This review addresses the possible role of the insulin‐like growth factor (IGF)‐axis in normal glucose homoeostasis and in the etiopathogenesis of type 2 diabetes. IGF‐I, a peptide hormone, shares amino acid sequence homology with insulin and has insulin‐like activity; most notably, the promotion of glucose uptake by peripheral tissues. Type 2 diabetes as well as pre‐diabetic states, including impaired fasting glucose and impaired glucose tolerance, are associated cross‐sectionally with altered circulating levels of IGF‐I and its binding proteins (IGFBPs). Administration of recombinant human IGF‐I has been reported to improve insulin sensitivity in healthy individuals as well as in patients with insulin resistance and type 2 diabetes. Further, IGF‐I may have beneficial effects on systemic inflammation, a risk factor for type 2 diabetes, and on pancreatic β‐cell mass and function. There is considerable inter‐individual heterogeneity in endogenous levels of IGF‐I and its binding proteins; however, the relationship between these variations and the risk of developing type 2 diabetes has not been extensively investigated. Large prospective studies are required to evaluate this association. Copyright © 2009 John Wiley & Sons, Ltd.
Diabetes/Metabolism: Research and Reviews – Wiley
Published: Jan 1, 2009
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.